XM tillhandahåller inte tjänster till personer bosatta i USA.

A
A

AstraZeneca

Nyheter

Reuters - 2 dagar sedan

J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug

UPDATE 3-J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug Adds analyst comment in paragraph 5, AstraZeneca statement in paragraph 9 By Bhanvi Satija Sept 28 (Reuters) - Johnson & Johnson JNJ.N said its cancer drug combination increased the time patients with a type of non small-cell lung cancer live without the disease worsening compared to AstraZeneca's AZN.L Tagrisso in a late-stage study.
A
Reuters - 4 dagar sedan

EU regulator to discuss anaesthesia risk for weight-loss drugs

EU regulator to discuss anaesthesia risk for weight-loss drugs By Ludwig Burger FRANKFURT, Sept 26 (Reuters) - The European Medicines Agency (EMA) will discuss the risk that patients on Wegovy, Ozempic or similar drugs may suffer certain complications under anaesthesia that can lead to pneumonia, according to an agenda posted on the regulator's website.
A
S
Reuters - 5 dagar sedan

Nasdaq top and bottom performing stocks at about 03:46 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:46 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change GE Healthcare Technologies Inc GEHC.OQ +3.2% Constellation Energy Corp CEG.OQ +2.3% Qualcomm Inc QCOM.OQ +2.0% Old Dominion Freight Line Inc ODFL.OQ +1.8% AstraZeneca PLC AZN.OQ +1.6% Bottom Performers Percent Change Warner Bros Discovery Inc WBD.OQ -3.5% Moderna Inc MRNA.OQ -2.4% JD.Com Inc JD.OQ -2.1% Dexcom Inc DXCM.OQ -1.9% Keurig Dr Pepper Inc KDP.OQ -1.9% The Nasdaq 100 .NDX
A
Q
U
D
O
Reuters - 5 dagar sedan

Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change GE Healthcare Technologies Inc GEHC.OQ +3.5% Old Dominion Freight Line Inc ODFL.OQ +2.3% Qualcomm Inc QCOM.OQ +1.8% AstraZeneca PLC AZN.OQ +1.7% Amazon.com Inc AMZN.OQ +1.6% Bottom Performers Percent Change Warner Bros Discovery Inc WBD.OQ -3.5% Moderna Inc MRNA.OQ -2.3% Zscaler Inc ZS.OQ -2.2% JD.Com Inc JD.OQ -2.1% Lululemon Athletica Inc LULU.OQ -1.9% The Nasdaq 100 .NDX gained
A
A
L
Q
U
O
Reuters - 5 dagar sedan

US stocks may not fall much more over shutdown, could rally after

LIVE MARKETS-US stocks may not fall much more over shutdown, could rally after STOXX Europe 600 down 0.9% China concerns weigh on markets German business sentiment worsens US stock futures inch lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com US STOCKS MAY NOT FALL MUCH MORE OVER SHUTDOWN, COULD RALLY AFTER (1243 GMT ) The Republican-controlled House of Representatives is du
A
B
E
G
N
U
U
B
R
U
E
F
U
Reuters - 5 dagar sedan

EU drugmakers: a safe haven with earnings strength

LIVE MARKETS-EU drugmakers: a safe haven with earnings strength STOXX Europe 600 down 0.9% China concerns weigh on markets German business sentiment worsens US stock futures inch lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EU DRUGMAKERS: A SAFE HAVEN WITH EARNINGS STRENGTH (1214 GMT) Morgan Stanley is upbeat about European drug stocks and believes the sector could offer
A
B
E
G
G
N
U
U
B
R
U
E
F
U
G
Reuters - 5 dagar sedan

Top of the Street: AstraZeneca, Close Brothers, Derwent London, Klepierre

BUZZ-Top of the Street: AstraZeneca, Close Brothers, Derwent London, Klepierre A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Jefferies raises AstraZeneca AZN.L to "buy" from "hold", saying the market has overlooked the company's pipeline beyond oncology, notably rescue asthma inhaler Airsupra that's set to launch in 2024 ** J.P.Morgan raises Close Brothers CBRO.L to "neutral" from "underweight", expecting a potential asset management division sale to s
A
C
C
D
J
K
S
T
Reuters - 5 dagar sedan

MS sees EU biopharma as 'safe heaven', prefers defensive earnings momentum

BUZZ-MS sees EU biopharma as 'safe heaven', prefers defensive earnings momentum ** Morgan Stanley anticipates EU biopharma to offer a "safe heaven" from weakening growth or higher real yields as it provides relatively high returns in an uncertain macroeconomic backdrop ** As inflationary pressures ease and COVID and inventory adversity fades the EU
A
N
Reuters - 5 dagar sedan

UK stocks kick off week lower, Entain drops to 3-year low

UPDATE 2-UK stocks kick off week lower, Entain drops to 3-year low For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Aviva drops on purchase of AIG's UK protection business unit Entain sinks on online gaming revenue warning AstraZeneca gains as Jefferies upgrades to buy FTSE 100 down 0.8%, FTSE 250 off 1.0% Updates to market close By Johann M Cherian and Shristi Achar A Sept 25 (Reuters) - UK stocks fell on Monday, in a grim start to the l
A
A
B
I
N
U
Reuters - 5 dagar sedan

China, rate woes send European stocks to one-month lows

UPDATE 2-China, rate woes send European stocks to one-month lows For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 down 0.8% German business morale falls Entain tumbles on revenue warning Updated at 1558 GMT By Bansari Mayur Kamdar and Sruthi Shankar Sept 25 (Reuters) - European shares closed at their weakest level in over a month on Monday as worries about interest rates staying elevated for longer and a slowing Chinese economy
A
K
L
F
E
F
G
Reuters - 6 dagar sedan

Close Brothers Group, Derwent London, Klepierre

EUROPE RESEARCH ROUNDUP-Close Brothers Group, Derwent London, Klepierre Sept 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Close Brothers Group, Derwent London and Klepierre, on Monday. HIGHLIGHTS * Adyen NV ADYEN.AS : Stifel cuts target price to EUR 720 from EUR 1,900 * Close Brothers Group Plc CBRO.L : JP Morgan raises to neutral from underweight * Derwent London Plc DLN.L : RBC raises to sector perform from underperform * K
A
A
B
B
B
C
C
D
D
G
H
I
K
S
S
B
J
Reuters - 6 dagar sedan

Japan's Nikkei rebounds from worst week of 2023 as chip, pharma stocks rally

Japan's Nikkei rebounds from worst week of 2023 as chip, pharma stocks rally By Kevin Buckland TOKYO, Sept 25 (Reuters) - Japan's Nikkei share average rebounded sharply on Monday as investors bought back beaten-down stocks following the benchmark index worst week of 2023. The Nikkei .N225 climbed 0.85% to end the day at 32,678.62. The broader Topix .TOPX rose 0.39%.
A
J
Reuters - 6 dagar sedan

Japan's Nikkei rebounds from worst week of 2023 after clearing BOJ, Fed tests

Japan's Nikkei rebounds from worst week of 2023 after clearing BOJ, Fed tests By Kevin Buckland TOKYO, Sept 25 (Reuters) - Japan's Nikkei share average rebounded sharply on Monday, as investors bought back beaten-down stocks after major risk events, including meetings of the U.S. Federal Reserve and the Bank of Japan, concluded. The Nikkei .N225 climbed 0.58% to 32,590.33 as of the midday recess.
A
J
Reuters - 1 vecka sedan

What you need to know about RSV and the new vaccines

EXPLAINER-What you need to know about RSV and the new vaccines Updates with CDC director signing off on Pfizer maternal vaccine By Michael Erman Sept 22 (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Friday recommended Pfizer's PFE.N respiratory syncytial virus (RSV) vaccine for women in the middle of the third trimester of pregnancy to protect their babies from severe illness.
A
G
P
S
S
Reuters - 1 vecka sedan

What you need to know about RSV and the new vaccines

EXPLAINER-What you need to know about RSV and the new vaccines Updates with Friday's CDC panel vote; adds Sanofi/AstraZeneca drug By Michael Erman Sept 22 (Reuters) - Expert advisers to U.S. Centers for Disease Control and Prevention (CDC) on Friday recommended Pfizer's PFE.N respiratory syncytial virus (RSV) vaccine for women in the middle of the third trimester of pregnancy to protect their babies from severe illness.
A
G
P
S
S
Reuters - 1 vecka sedan

US CDC backs Pfizer's maternal RSV vaccine to protect infants

UPDATE 2-US CDC backs Pfizer's maternal RSV vaccine to protect infants Updates first paragraph with CDC recommendation, adds director comment in paragraph 3 By Sriparna Roy and Michael Erman Sept 22 (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's PFE.N respiratory syncytial virus (RSV) vaccine for women in the middle of the third trimester of pregnancy to protect their babies from severe illness.
A
G
P
S
Reuters - 1 vecka sedan

European shares clock weekly decline as higher-for-longer rates loom

UPDATE 2-European shares clock weekly decline as higher-for-longer rates loom For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 off 0.3%, down 1.9% for the week France's services sector contracts sharply in Sept - flash PMI AstraZeneca rises as breast cancer drug meets goal in study Shrinking German business activity points to Q3 contraction - PMI Updated at 1602 GMT By Bansari Mayur Kamdar and Shashwat Chauhan Sept 22 (Reuters)
A
E
I
A
E
F
U
G
Reuters - 1 vecka sedan

AstraZeneca rises after breast cancer drug meets main trial goal

BUZZ-AstraZeneca rises after breast cancer drug meets main trial goal ** U.S.-listed shares of AstraZeneca AZN.L rise 2.3% to $68.56 premarket ** The U.K-based drugmaker says its experimental precision drug slowed progression of breast cancer in a late-stage trial ** Co is jointly developing the drug, datopotamab deruxtecan, with Japan's Daiichi Sa
A
Reuters - 1 vecka sedan

FTSE 100 ends week lower on higher for longer rates outlook

UPDATE 2-FTSE 100 ends week lower on higher for longer rates outlook For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window AstraZeneca up drug trial success UK's August retail sales partially recovers FTSE 100 up 0.1%, FTSE 250 off 0.2% Updated at 1550 GMT By Siddarth S and Shubham Batra Sept 22 (Reuters) - Britain's FTSE 100 edged higher on Friday, but logged weekly declines after the Bank of England joined other central banks this week in si
A
A
E
G
J
O
P
N
U
Reuters - 1 vecka sedan

European shares set for weekly drop as higher-for-longer rates loom

UPDATE 1-European shares set for weekly drop as higher-for-longer rates loom For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 off 0.3%, down 1.9% so far this week France's services sector contracts sharply in Sept - flash PMI AstraZeneca rises as breast cancer drug meets goal in study Shrinking German business activity points to Q3 contraction-PMI Updated at 0745 GMT By Bansari Mayur Kamdar Sept 22 (Reuters) - European shares sl
A
E
E
F
U
G

Villkor

Populära tillgångar

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Vi använder cookies för att ge dig den bästa upplevelsen på vår webbplats. Läs mer eller ändra dina cookie-inställningar.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.